Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Financial Flexibility Index
Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥28.14 Million (operating CF CN¥22.69 Million minus capex CN¥5.45 Million) represents 0% of total liabilities (CN¥2.09 Billion). Check 600222 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Henan Taloph Pharmaceutical Stock Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Henan Taloph Pharmaceutical Stock Co Ltd across 28 annual periods. See Henan Taloph Pharmaceutical Stock Co Ltd (600222) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Henan Taloph Pharmaceutical Stock Co Ltd. For the full company profile including market capitalisation, see Henan Taloph Pharmaceutical Stock Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | CN¥68.28 Million | CN¥47.16 Million | CN¥1.98 Billion | ▲ +2831.4% |
| 2024 | 0.00x | CN¥-2.35 Million | CN¥-39.59 Million | CN¥1.86 Billion | ▼ -102.8% |
| 2023 | 0.04x | CN¥86.87 Million | CN¥43.74 Million | CN¥1.95 Billion | ▲ +252.9% |
| 2022 | -0.03x | CN¥-57.78 Million | CN¥-124.41 Million | CN¥1.99 Billion | ▼ -142.1% |
| 2021 | 0.07x | CN¥138.73 Million | CN¥99.66 Million | CN¥2.01 Billion | ▼ -12.0% |
| 2020 | 0.08x | CN¥146.08 Million | CN¥73.43 Million | CN¥1.86 Billion | ▼ -24.8% |
| 2019 | 0.10x | CN¥149.20 Million | CN¥41.53 Million | CN¥1.43 Billion | ▼ -18.8% |
| 2018 | 0.13x | CN¥185.88 Million | CN¥119.47 Million | CN¥1.44 Billion | ▲ +147.8% |
| 2017 | 0.05x | CN¥67.51 Million | CN¥23.17 Million | CN¥1.30 Billion | ▼ -54.1% |
| 2016 | 0.11x | CN¥130.21 Million | CN¥70.60 Million | CN¥1.15 Billion | ▲ +15.9% |
| 2015 | 0.10x | CN¥111.31 Million | CN¥49.27 Million | CN¥1.14 Billion | ▼ -13.8% |
| 2014 | 0.11x | CN¥125.17 Million | CN¥89.54 Million | CN¥1.11 Billion | ▲ +525.0% |
| 2013 | 0.02x | CN¥15.60 Million | CN¥-6.65 Million | CN¥861.22 Million | ▼ -83.8% |
| 2012 | 0.11x | CN¥102.35 Million | CN¥87.45 Million | CN¥912.93 Million | ▲ +44.5% |
| 2011 | 0.08x | CN¥64.52 Million | CN¥105.20K | CN¥831.28 Million | ▲ +634.9% |
| 2010 | 0.01x | CN¥6.78 Million | CN¥-20.00 Million | CN¥641.92 Million | ▼ -89.2% |
| 2009 | 0.10x | CN¥49.70 Million | CN¥21.45 Million | CN¥506.12 Million | ▼ -36.6% |
| 2008 | 0.15x | CN¥59.11 Million | CN¥18.13 Million | CN¥381.43 Million | ▼ -21.4% |
| 2007 | 0.20x | CN¥63.75 Million | CN¥21.34 Million | CN¥323.29 Million | ▲ +66.2% |
| 2006 | 0.12x | CN¥38.23 Million | CN¥1.59 Million | CN¥322.24 Million | ▲ +59.5% |
| 2005 | 0.07x | CN¥20.73 Million | CN¥276.30K | CN¥278.70 Million | ▼ -36.4% |
| 2004 | 0.12x | CN¥33.15 Million | CN¥18.25 Million | CN¥283.44 Million | ▲ +52.1% |
| 2003 | 0.08x | CN¥20.63 Million | CN¥3.74 Million | CN¥268.36 Million | ▲ +47.2% |
| 2002 | 0.05x | CN¥13.82 Million | CN¥7.47 Million | CN¥264.70 Million | ▼ -90.5% |
| 2001 | 0.55x | CN¥113.76 Million | CN¥55.03 Million | CN¥206.07 Million | ▼ -17.7% |
| 2000 | 0.67x | CN¥108.99 Million | CN¥875.36K | CN¥162.45 Million | ▼ -43.4% |
| 1999 | 1.19x | CN¥179.18 Million | CN¥99.32 Million | CN¥151.10 Million | ▲ +596.0% |
| 1998 | 0.17x | CN¥28.08 Million | CN¥28.04 Million | CN¥164.79 Million | — |